# Use of Spectral OCT in Combination Therapy

> **NCT01025063** · — · COMPLETED · sponsor: **Barnes Retina Institute** · enrollment: 15 (actual)

## Conditions studied

- Choroidal Neovascularization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01025063
- **Lead sponsor:** Barnes Retina Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025063, "Use of Spectral OCT in Combination Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01025063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*